Interest in functional service model on the rise; Chiltern

By Nick Taylor

- Last updated on GMT

Related tags Project management Management

Biopharm is increasingly using the functional service provider (FSP) model, in areas such as medical affairs and statistical services, while continuing to globalise trials, according to Chiltern.

The FSP model, in theory, minimises project management, allows big pharma to leverage scale in pricing, and supports harmonisation of standards and processes. Biopharm is now requesting FSP more often, Pat Ling, director of global key accounts at Chiltern, told Outsourcing-Pharma.

Chiltern already has a number of FSP relationships with sponsors, said Ling. “This is not a huge alteration on our part​”, said Ling, “we already have the experience and ability​”.

Related news

Show more

Related products

show more

The Right CDMO Can Unlock Faster Drug Development

The Right CDMO Can Unlock Faster Drug Development

Content provided by Lonza Small Molecules | 15-May-2023 | Interview

Drug development presents biotech companies with ever-changing challenges. Enabling a faster end-to-end process requires seamless flexibility and extensive...

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 25-Apr-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Related suppliers

Follow us


View more